ReviewTheranostics2026
Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy.
Jiaqi Xing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewTheranostics2026
Jiaqi Xing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.